These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16055379)

  • 1. Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias.
    Agostino R; Bagnato S; Dinapoli L; Modugno N; Berardelli A
    Clin Neurophysiol; 2005 Sep; 116(9):2077-82. PubMed ID: 16055379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
    Liu X; Carroll CB; Wang SY; Zajicek J; Bain PG
    J Neurosci Methods; 2005 May; 144(1):47-52. PubMed ID: 15848238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
    Ghassemi M; Lemieux S; Jog M; Edwards R; Duval C
    Brain Res Bull; 2006 May; 69(5):512-8. PubMed ID: 16647580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
    Gour J; Edwards R; Lemieux S; Ghassemi M; Jog M; Duval C
    Brain Res Bull; 2007 Sep; 74(1-3):66-74. PubMed ID: 17683791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparkinson medications improve agonist activation but not antagonist inhibition during sequential reaching movements.
    Kelly VE; Bastian AJ
    Mov Disord; 2005 Jun; 20(6):694-704. PubMed ID: 15719427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of sequential arm movements with and without advance knowledge of motor pathways in Parkinson's disease.
    Currà A; Berardelli A; Agostino R; Modugno N; Puorger CC; Accornero N; Manfredi M
    Mov Disord; 1997 Sep; 12(5):646-54. PubMed ID: 9380044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dyskinesia caused by L-DOPA].
    Derkinderen P; Vidailhet M
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of dyskinesias in Parkinson's disease.
    Mouradian MM; Heuser IJ; Baronti F; Fabbrini G; Juncos JL; Chase TN
    Ann Neurol; 1989 May; 25(5):523-6. PubMed ID: 2774496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
    Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease.
    Mann RK; Edwards R; Zhou J; Jog M; Duval C
    Clin Neurol Neurosurg; 2010 Jun; 112(5):392-9. PubMed ID: 20206438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Computerized method for arm movement assessment in Parkinson's disease and cerebellar syndrome patients].
    Dordević O; Popović MB; Kostić V
    Srp Arh Celok Lek; 2005; 133(1-2):14-20. PubMed ID: 16053170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.
    Zappia M; Annesi G; Nicoletti G; Arabia G; Annesi F; Messina D; Pugliese P; Spadafora P; Tarantino P; Carrideo S; Civitelli D; De Marco EV; Cirò-Candiano IC; Gambardella A; Quattrone A
    Arch Neurol; 2005 Apr; 62(4):601-5. PubMed ID: 15824260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral sequential arm movements after unilateral subthalamic deep-brain stimulation in patients with Parkinson's disease.
    Agostino R; Dinapoli L; Modugno N; Iezzi E; Gregori B; Esposito V; Romanelli P; Berardelli A
    Mov Disord; 2008 Sep; 23(12):1718-24. PubMed ID: 18661566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A; Jog MS; Duval C
    Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
    Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset and spread of dyskinesias and motor symptoms in Parkinson's disease.
    Fabbrini G; Defazio G; Colosimo C; Suppa A; Bloise M; Berardelli A
    Mov Disord; 2009 Oct; 24(14):2091-6. PubMed ID: 19691126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathology of the dyskinesias induced by L-dopa].
    Grandas F; López-Ariztegui N
    Rev Neurol; 1997 Aug; 25 Suppl 2():S151-6. PubMed ID: 9280682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A paradoxical acute effect of levodopa in de novo parkinsonian patients: worsening of some bradykinetic components.
    Pasetti C; Lualdi MM; Pinelli P
    Neurol Sci; 2003 Oct; 24(3):201-2. PubMed ID: 14598087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.